US2005118175A1PendingUtilityA1

Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics

65
Assignee: BIOGEN IDEC INCPriority: Feb 20, 1997Filed: Dec 6, 2004Published: Jun 2, 2005
Est. expiryFeb 20, 2017(expired)· nominal 20-yr term from priority
Inventors:Mitchell E. ReffWilliam KloetzerTakehiko Nakamura
C07K 16/2851C07K 2319/00C07K 2317/24A61K 38/00
65
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods for inhibiting IgE production in a human subject using anti-CD23 antibodies.

Claims

exact text as granted — not AI-modified
1 . An anti-human CD23 monoclonal antibody comprising a human gamma-1 constant region that inhibits IgE expression.  
     
     
         2 - 37 . (canceled)

Join the waitlist — get patent alerts

Track US2005118175A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.